BridgeBio Pharma Other Non-Current Liabilities 2018-2024 | BBIO
BridgeBio Pharma other non-current liabilities for the quarter ending June 30, 2024 were $0.000B, a 96.36% decline year-over-year.
- BridgeBio Pharma other non-current liabilities for 2023 were $0.009B, a 64.87% decline from 2022.
- BridgeBio Pharma other non-current liabilities for 2022 were $0.027B, a 20.73% increase from 2021.
- BridgeBio Pharma other non-current liabilities for 2021 were $0.022B, a 131.82% increase from 2020.